Skip to main content
. 2010 Oct 21;16(39):4913–4921. doi: 10.3748/wjg.v16.i39.4913

Table 4.

Food and Drug Administration approved drugs for prophylaxis and treatment of hereditary angioedema attacks[18,34,35,37,38,40]

Drug FDA approved indication Usual adult dose Range
Cinryze Prophylaxis 1000 units IV Every 3rd or 4th day
Danazol Prophylaxis 200 mg/d 100 mg every 3rd day to 600 mg/d
Berinert Acute attacks 20 units/kg body weight IV Per attack
Icatibant Acute attacks 30 mg SQ Per attack
Ecallantide Acute attacks 30 mg SQ Per attack

FDA: Food and Drug Administration.